
The future of IP protections for COVID-19 vaccines and beyond (with Michael Rosen)
Intellectual property (IP) has been a hot topic due to the Biden administration’s support of a proposal to waive the World Trade Organization’s Trade-Related Aspects of Intellectual Property Rights (TRIPS) for COVID-19 vaccines and treatments. Some argue IP protections incentivized vaccine manufacturers to produce what are now the world’s antidotes to the pandemic. But others say these protections are slowing down global vaccination and distribution rates — especially in the developing world. Why did the administration take this stance, and what might this signal about its approach to other…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.